YiLoLife, Inc. - Commentary and News -
January 31, 2017
Largest U.S. Banks Host Accounts
for Marijuana Businesses, Says American Banker
Palm Beach, FL --January 31, 2017 -- A recent study1 commissioned by
industry journal American Banker reveals that the nation’s four largest banks
have opened accounts for pot shops and marijuana-related businesses. This is
good news for companies like Cannabis Science Inc. (CBIS), Eco Science
Solutions, Inc. (ESSI), Medical Marijuana, Inc. (MJNA), Marijuana Company of
America Inc. (MCOA), mCig, Inc. (MCIG) and
YiLoLife, Inc. – all of which
provide a variety of services or interest to the marijuana community and would
benefit from commercial banking services.
Conducted by MRB Monitor, a firm that helps financial institutions identify the
risks associated with the marijuana industry, the study examined public records
in the state of Massachusetts and found that 34 percent of businesses that filed
to operate medical marijuana dispensaries in Massachusetts between June 2015 and
September 2016 had one or more accounts at Bank of America, Citigroup, Wells
Fargo, or JPMorgan Chase.
If a similar pattern of working with the marijuana industry takes hold in
Washington D.C. and the U.S. states that have legalized marijuana, the prospect
of financial services for cannabis outfits may not be as dire as it at first
appears.
Bank of America seems to have been the most accommodating. Over half of the
marijuana businesses included in the survey had accounts at the bank, though it
previously told the Statesman Journal2 that “as a federally regulated financial
institution, we abide by federal law and do not bank marijuana-related
businesses.”
Guidelines issued by federal authorities in 2014 appeared to have offered
financial institutions a legal avenue to provide their services to
marijuana-related businesses (MRBs). Back then, the Financial Crimes Enforcement
Network (FinCEN), part of the U.S. Treasury Department, provided guidance3 it
said was meant to “enhance the availability of financial services for, and the
financial transparency of, marijuana-related businesses.”
Yet, under the Controlled Substances Act (CSA), it is illegal to manufacture,
distribute, or dispense marijuana, and marijuana - like heroin, LSD and ecstasy
– remains a Schedule 1 substance under the statute.
In December 2016, U.S. Senator Elizabeth Warren, D-Mass, a member of the Senate
Banking Committee, along with nine other senators sent a letter to FinCEN
requesting guidance on how banking services might be offered to “indirect
businesses” that “provide services to the state-sanctioned marijuana industry.”
Hopefully, after nomination season comes to a close, a response to that letter
will be forthcoming; there’s a lot at stake. As ArcView Market Research wrote,
“Cannabis is arguably the fastest growing industry in the world. Regulated
marijuana sales in North America totaled $6.9 billion in 2016, a 30 percent
increase from 2015. Sales are projected to increase to $21.6 billion by the year
2021 representing a 26 percent compound annual growth rate.”
YiLoLife is gearing up to reap this
burgeoning marijuana harvest. The company recently offered up to 5 million
shares of its Class A common stock, at a price of $3.28 per share, under a
Regulation A+ filing. YiLoLife
plans to use some $12 million from this share offering in adding capital assets,
as well as toward the acquisition and development of cultivation, food
processing and distribution facilities. A further $1.5 million will be expended
on equipment, furniture and fixtures and $1.0 million will go to improve
security. The remaining $1.9 million will be allocated toward bolstering working
capital.
Other industry players are also positioning themselves. Cannabis Science (CBIS)
is a biotech company that discovers and develops novel cannabinoid-based
therapies to those critically in need of new treatments for life threatening and
debilitating conditions. Eco Science Solutions, Inc. (ESSI) is a Hawaii-based
technology company targeting the multi-billion dollar health and wellness
industry.
Marijuana Company of America (MCOA) is a marketing and distribution company that
plans to deliver all the benefits of cannabis by providing a wide range of
services for cannabis businesses and entrepreneurs. The company focuses on
leisure, wellness, health, and beauty-specific cannabis products.
And last but not least is mCig (MCIG). Driven by a management team with over 75
years of combined experience, this is a company that provides turnkey, durable,
modular, ISO clean, high-yielding cultivation rooms to marijuana growers.
*Sources:
1. American Banker http://dtn.fm/VAWa8
2. Statesman Journal http://dtn.fm/coPF7
3. FinCEN http://dtn.fm/SB8p6
For more information on YiLo please visit the company’s crowd-funding page at
http://www.yilo.com/stocks2850
Please read all Disclaimers for FULL Compensation Disclosures and other
disclaimers
Yilo Disclosure & DTN
Disclaimer
DISCLAIMER: DTN is source of content listed above. FN Media Group, LLC (FNM), is
a third party publisher and news dissemination service provider, which
disseminates electronic information through multiple online media channels. FNM
is NOT affiliated with DTN expressed in this release by DTN are solely those of
DTN and are not shared by and do not reflect in any manner the views or opinions
of FNM. DTN & FNM is not liable for any investment decisions by its readers or
subscribers. FNM and its affiliated companies are a news dissemination and
financial marketing solutions provider and are NOT a registered
broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell,
offer to sell or offer to buy any security. FNM was not compensated by any
public company mentioned herein to disseminate this press release.
DTN & FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains "forward-looking statements" within the meaning of Section
27A of the Securities Act of 1933, as amended, and Section 21E the Securities
Exchange Act of 1934, as amended and such forward-looking statements are made
pursuant to the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995. "Forward-looking statements" describe future expectations,
plans, results, or strategies and are generally preceded by words such as "may",
"future", "plan" or "planned", "will" or "should", "expected," "anticipates",
"draft", "eventually" or "projected". You are cautioned that such statements are
subject to a multitude of risks and uncertainties that could cause future
circumstances, events, or results to differ materially from those projected in
the forward-looking statements, including the risks that actual results may
differ materially from those projected in the forward-looking statements as a
result of various factors, and other risks identified in a company's annual
report on Form 10-K or 10-KSB and other filings made by such company with the
Securities and Exchange Commission. You should consider these factors in
evaluating the forward-looking statements included herein, and not place undue
reliance on such statements. The forward-looking statements in this release are
made as of the date hereof and DTN & FNM undertakes no obligation to update such
statements.
Source: Dreamteamnetwork.com
----------------------------------------------------------------------------
RECENT YILOLIFE DEVELOPMENTS AND ARTICLES
YiLoLife, Inc. Public Offering
Gives General Public Ground Floor Opportunity to Invest In Legal Marijuana
Market, Expected To Jump From $7 Billion to $40 Billion Over Next 5-10 Years
January 9, 2017 - YiLoLife,
Inc., an expanding company providing management and support services to
the legal medical marijuana (MMJ) industry, is now open for investment to the
general public through an SEC approved Regulation A+ public offering. This
represents a ground floor opportunity for investors as the first in three
planned investment rounds:
1.First round is now approved by Security Exchange Commission with limited 5
million YiLo Shares for first public offering with a share value of $3.28
2.Second round with an approximate share value of about $8 – $10
3.Third round with an approximate share value of about $15
Arizona based YiLoLife was founded to address a significant unmet need in the
medical marijuana industry. Products were being produced and sold with little
concern for taste, proper standards, and selection. The fast growth of the MMJ
market allowed lax quality, with businesses making money in spite of weak
products. The YiLo™ brand was created to upgrade all aspects of the industry and
its offerings. Today, the YiLo™ brand represents the top-of-the-line in product
and operational quality, offering over 600 MMJ products and attracting a loyal
customer base. With German quality standards ensuring consistent medical levels,
and unsurpassed taste quality, it is now the fastest growing seed-to-shelf
marijuana-related brand in Arizona. Natural Relief Clinic, Inc. (NRC),
YiLoLife’s exclusive client, markets YiLo™ products through specialized
dispensaries across Arizona and its MMJ YiLo Superstore located at 2841 W.
Thunderbird Rd in Phoenix. In addition, YiLoLife intends to natively replicate
its model by contracting with newly organized non-profit MMJ organization(s) on
an exclusive basis, beginning with California.
This first round mini IPO-style public offering, under Regulation A+ of the Jobs
Act, targets a $16.4 million fundraise, with net proceeds to be used for
acquisition and development of cultivation, food processing, and distribution
facilities, as well as for working capital. The offering gives the general
public the opportunity to invest in YiLoLife’s rapid growth in providing
services to the legal marijuana market, which is on pace to become one of the
fastest growing industries in the United States.
See the YiLo crowdfunding platform at http://www.yilo.com/stocks2842, and the
YiLoLife website at www.yilo.com.
Source: YiLoLife, Inc.
YiLoLife, Inc. Supporting
Arizona Bill to Legalize Recreational Use Despite Failed Vote
December 29, 2016 - Last month, Arizona narrowly rejected an initiative
to legalize recreational marijuana use, but supporters of legalization are not
discouraged by the failed vote and are already mobilizing to find alternative
ways for the substance to become fully legal statewide. While a new proposition
is being drafted for the next election, an Arizona lawmaker is considering a
different approach that would get recreational marijuana use legalized through
the state legislature, if successful, according to the Tenth Amendment Center
blog.
The bill was prefiled for introduction during the 2017 legislative session by
Rep. Mark Cardenas (D-Louisville), and if it is passed, it would mark a big step
toward virtually annulling federal cannabis prohibition as well. Cardenas’s
House Bill 2003 (HB2003) shares many similarities with Proposition 205, which
was rejected in the November election by a narrow margin: 51.32 percent voted
against recreational legalization and 48.68 percent voted in favor. Prop 205 was
sponsored by the Coalition for the Regulation of Marijuana like Alcohol and
supported by several dispensaries, medical marijuana manufacturers and other
organizations, including YiLoLife,
Inc., a holding company. The YiLo™ branded product line represents
popular, top-quality MMJ products.
If successful, HB2003 would allow any individual age 21 or above to possess,
use, display, purchase, consume or transport up to one ounce of marijuana, or up
to five marijuana plants and the cannabis produced by those plants at their
location. Additionally, any individual over the age of 21 would be permitted to
transfer up to one ounce of marijuana and five immature marijuana plants to
another person of legal age, without remuneration. The bill would also allow any
individual of legal age to assist another person who is at least 21 in any of
the acts listed above.
Furthermore, the bill would enforce an excise tax of $50 per marijuana ounce,
with half the revenue so collected going to the general fund and the other half
going toward health and educational programs. The Department of Health Services
would be tasked with regulating the recreational cannabis industry in the state,
while marijuana retailers and vendors would be required to register and get
local and state officials’ approval for their business locations. Under HB2003,
if any individual under 21 is caught possessing up to one ounce of marijuana,
they would be required to either pay a fee of up to $300 or take part in a
diversion program.
If the bill is successful during next year’s legislative session, Arizona will
be the first state to legalize the recreational use of marijuana through its
legislature instead of a ballot initiative process. In addition, passage of the
bill would basically nullify the current federal prohibition on marijuana, with
the Drug Enforcement Agency still listing cannabis among Schedule I controlled
substances. Several states are already ignoring the prohibition, as more than
two dozen allow medical marijuana use and eight others allow recreational use,
as well.
In Arizona, YiLoLife remains a staunch supporter of legalization, constantly
committed to educating the general public about the benefits of marijuana. The
YiLo™ brand now offers an impressive, award-winning line of more than 600
medical marijuana products, available for patients suffering from various
ailments, from glaucoma and Hepatitis C to cancer, HIV/AIDS, Alzheimer’s,
Chron’s disease, PTSD, Amyotrophic Lateral Sclerosis and more.
Source: YiLoLife, Inc.
Disclaimer
FN Media Group LLC (FNMG) owns and operates
FinancialNewsMedia.com (FNM)
which is a third party publisher that disseminates electronic information
through multiple online media channels. FNMG's intended purposes are to deliver
market updates and news alerts issued from private and publicly trading
companies as well as providing coverage and increased awareness for companies
that issue press to the public via online newswires. FNMG and its affiliated
companies are a news dissemination and financial marketing solutions provider
and are NOT a registered broker/dealer/analyst/adviser, holds no investment
licenses and may NOT sell, offer to sell or offer to buy any security. FNMG's
market updates, news alerts and corporate profiles are NOT a solicitation or
recommendation to buy, sell or hold securities. The material in this release is
intended to be strictly informational and is NEVER to be construed or
interpreted as research material. All readers are strongly urged to perform
research and due diligence on their own and consult a licensed financial
professional before considering any level of investing in stocks. The companies
that are discussed in this release may or may not have approved the statements
made in this release. Information in this release is derived from a variety of
sources that may or may not include the referenced company's publicly
disseminated information. The accuracy or completeness of the information is not
warranted and is only as reliable as the sources from which it was obtained.
While this information is believed to be reliable, such reliability cannot be
guaranteed. FNMG disclaims any and all liability as to the completeness or
accuracy of the information contained and any omissions of material fact in this
release. This release may contain technical inaccuracies or typographical
errors. It is strongly recommended that any purchase or sale decision be
discussed with a financial adviser, or a broker-dealer, or a member of any
financial regulatory bodies. Investment in the securities of the companies
discussed in this release is highly speculative and carries a high degree of
risk. FNMG is not liable for any investment decisions by its readers or
subscribers. Investors are cautioned that they may lose all or a portion of
their investment when investing in stocks. This release is not without bias, and
is considered a conflict of interest if compensation has been received by FNMG
for its dissemination. To comply with Section 17(b) of the Securities Act of
1933, FNMG shall always disclose any compensation it has received, or expects to
receive in the future, for the dissemination of the information found herein on
behalf of one or more of the companies mentioned in this release. For current
services performed FNMG has been compensated one thousand eight hundred dollars for
this news coverage by a non-affiliated third party.. FNMG HOLDS NO SHARES
OF ANY COMPANY MENTIONED HEREIN.
This release contains "forward-looking statements" within the meaning of Section
27A of the Securities Act of 1933, as amended, and Section 21E the Securities
Exchange Act of 1934, as amended and such forward-looking statements are made
pursuant to the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995. "Forward-looking statements" describe future expectations,
plans, results, or strategies and are generally preceded by words such as "may",
"future", "plan" or "planned", "will" or "should", "expected," "anticipates",
"draft", "eventually" or "projected". You are cautioned that such statements are
subject to a multitude of risks and uncertainties that could cause future
circumstances, events, or results to differ materially from those projected in
the forward-looking statements, including the risks that actual results may
differ materially from those projected in the forward-looking statements as a
result of various factors, and other risks identified in a company's annual
report on Form 10-K or 10-KSB and other filings made by such company with the
Securities and Exchange Commission. You should consider these factors in
evaluating the forward-looking statements included herein, and not place undue
reliance on such statements. The forward-looking statements in this release are
made as of the date hereof and FNMG undertakes no obligation to update such
statements.
|